Chris Degnan - Chief Financial Officer at UroGen Pharma Ltd.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
URGN on Nasdaq
All Insider Reports
All Insider Reports

Chris Degnan - trading volume in the past year for UroGen Pharma Ltd.

Holdings reported by Chris Degnan for UroGen Pharma Ltd.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Ordinary Shares 2.28K $38.4K $16.85 Oct 8, 2025 Direct
Employee Stock Option (right to buy) 74.1K Oct 8, 2024 Direct Ordinary Shares
Restricted Stock Units 8.97K Oct 8, 2025 Direct Ordinary Shares

Transactions reported by Chris Degnan for UroGen Pharma Ltd.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.